Antibiotic resistance: a global crisis, problems and solutions

References

• Afroza S. 2006. Neonatal sepsis–a global problem: an overview. Mymensingh Med J. 15(1):108–114. doi:10.3329/mmj.v15i1.2.
   PubMedGoogle Scholar
• Ahmad M, Khan AU. 2019. Global economic impact of antibiotic resistance: a review. J Glob Antimicrob Resist. 19:313–316. doi:10.1016/j.jgar.2019.05.024.
   PubMed Web of Science ®Google Scholar
• Ahmadian L, Haghshenas MR, Mirzaei B, Khalili Y, Goli HR. 2023. Role of MexAB-OprM efflux pump in the emergence of multidrug-resistant clinical isolates of Pseudomonas aeruginosa in Mazandaran province of Iran. Mol Biol Rep. 50(3):2603–2609. doi:10.1007/s11033-022-08230-2.
   PubMed Web of Science ®Google Scholar
• Ahmadzai MA, Shinwari Q, Al-Rasheed AA, Garba B. 2022. Armed conflict and the proliferation of antimicrobial resistance: the situation in war–ravaged Afghanistan. Int J One Health. 8(1):43–47. doi:10.14202/IJOH.2022.43-47.
   Google Scholar
• Akova M. 2016. Epidemiology of antimicrobial resistance in bloodstream infections. Virulence. 7(3):252–266. doi:10.1080/21505594.2016.1159366.
   PubMed Web of Science ®Google Scholar
• Alikhan N-F, Moreno LZ, Castellanos LR, Chattaway MA, McLauchlin J, Lodge M, O’Grady J, Zamudio R, Doughty E, Petrovska L, et al. 2022. Dynamics of Salmonella enterica and antimicrobial resistance in the Brazilian poultry industry and global impacts on public health. PLoS Genet. 18(6):e1010174. doi:10.1371/journal.pgen.1010174.
   PubMed Web of Science ®Google Scholar
• AlMatar M, Albarri O, Makky EA, Köksal F. 2021. Efflux pump inhibitors: new updates. Pharmacol Rep. 73(1):1–16. doi:10.1007/s43440–020–00160–9.
   PubMed Web of Science ®Google Scholar
• AlSheikh HM, Sultan I, Kumar V, et al. 2020. Plant–based phytochemicals as possible alternative to antibiotics in combating bacterial drug resistance. Antibiotics. 9(8):480. doi:10.3390/antibiotics9080480.
   Google Scholar
• Anand A, Sharma A, Ravins M, Biswas D, Ambalavanan P, Lim KXZ, Tan RYM, Johri AK, Tirosh B, Hanski E, et al. 2021. Unfolded protein response inhibitors cure group A streptococcal necrotizing fasciitis by modulating host asparagine. Sci Transl Med. 13(605):eabd7465. doi:10.1126/scitranslmed.abd7465.
   PubMed Web of Science ®Google Scholar
• Annunziato G. 2019. Strategies to overcome antimicrobial resistance (AMR) making use of non–essential target inhibitors: a review. Int J Mol Sci. 20(23):5844. doi:10.3390/ijms20235844.
   PubMed Web of Science ®Google Scholar
• Antimicrobial resistance through the looking–GLASS. 2023. Editorial. Lancet Infect Dis. 23(2):131. doi:10.1016/S1473-3099(23)00012-9.
   PubMedGoogle Scholar
• Anwar M, Iqbal Q, Saleem F. 2020. Improper disposal of unused antibiotics: an often overlooked driver of antimicrobial resistance. Expert Rev anti Infect Ther. 18(8):697–699. doi:10.1080/14787210.2020.1754797.
   PubMed Web of Science ®Google Scholar
• Argimón S, David S, Underwood A, Abrudan M, Wheeler NE, Kekre M, Abudahab K, Yeats CA, Goater R, Taylor B, et al. 2021. Rapid genomic characterization and global surveillance of Klebsiella using pathogenwatch. Clin Infect Dis. 73(Suppl_4):S325–S335. doi:10.1101/2021.06.22.448967.
   PubMedGoogle Scholar
• Argimón S, Nagaraj G, Shamanna V, Sravani D, Vasanth AK, Prasanna A, Poojary A, Bari AK, Underwood A, Kekre M, et al. 2022. Circulation of third–generation cephalosporin resistant Salmonella typhi in Mumbai, India. Clin Infect Dis. 74(12):2234–2237. doi:10.1093/cid/ciab897.
   PubMed Web of Science ®Google Scholar
• Argimón S, Yeats CA, Goater RJ, Abudahab K, Taylor B, Underwood A, Sánchez-Busó L, Wong VK, Dyson ZA, Nair S, et al. 2021. A global resource for genomic predictions of antimicrobial resistance and surveillance of Salmonella typhi at pathogenwatch. Nat Commun. 12(1):2879. doi:10.1101/2020.07.03.186692.
   PubMed Web of Science ®Google Scholar
• Ashwath P, Sannejal AD. 2022. The action of efflux pump genes in conferring drug resistance to Klebsiella Species and their inhibition. J. health Allied Sci. NU. 12(01):24–31. doi:10.1055/s-0041-1731914.
   Google Scholar
• Askoura M, Mottawea W, Abujamel T, Taher I. 2011. Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa. Libyan J Med. 6(1):5870. doi:10.3402/ljm.v6i0.5870.
   Google Scholar
• Aslam B, Rasool M, Idris A, et al. 2020. CRISPR–Cas system: a potential alternative tool to cope antibiotic resistance. Antimicrob Resist Infect. 9(1):1–3. doi:10.1186/s13756–020–00795–6.
   PubMed Web of Science ®Google Scholar
• Aslan AT, Akova M, Paterson DL. 2022. Next-generation polymyxin class of antibiotics: a ray of hope illuminating a dark road. Antibiotics (Basel). 11(12):1711. doi:10.3390/antibiotics11121711.
   PubMed Web of Science ®Google Scholar
• Barcelos VT, Silva CT, Fernandes SF, et al. 2022. Spread of multidrug–resistant Acinetobacter baumannii isolates belonging to IC1 and IC5 major clones in Rondônia state. Brazilian J. Microbiol. 53(2):795–799. doi:10.1007/s42770–022–00706–4.
   PubMed Web of Science ®Google Scholar
• Bartoszko JJ, Mitchell R, Katz K, Mulvey M, Mataseje L, Canadian Nosocomial Infection Surveillance Program (CNISP) Carbapenemase-Producing Organisms (CPO) Working Group. 2022. Characterization of Extensively drug–resistant (XDR) Carbapenemase–producing Enterobacterales (CPE) in Canada from 2019 to 2020. Microbiol Spectr. 10(4):e00975–22. doi:10.1128/spectrum.00975–22.
   PubMed Web of Science ®Google Scholar
• Benigno TG, Ribeiro Junior HL, Azevedo OG, et al. 2022. Clarithromycin–resistant H. pylori primary strains and virulence genotypes in the northeastern region of Brazil. Rev Inst Med Trop São Paulo. 64:1–9. doi:10.1590/S1678–9946202264047.
   Web of Science ®Google Scholar
• Blair JM, Richmond GE, Piddock LJ. 2014. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 9(10):1165–1177. doi:10.2217/fmb.14.66.
   PubMed Web of Science ®Google Scholar
• Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. 2015. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 13(1):42–51. doi:10.1038/nrmicro3380.
   PubMed Web of Science ®Google Scholar
• Bloemberg GV, Keller PM, Stucki D, Trauner A, Borrell S, Latshang T, Coscolla M, Rothe T, Hömke R, Ritter C, et al. 2015. Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis. N Engl J Med. 373(20):1986–1988. doi:10.1056/NEJMc1505196.
   PubMed Web of Science ®Google Scholar
• Bouvet PJ, Grimont PA. 1986. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J Syst Evol Microbiol. 36(2):228–240. doi:10.1099/00207713-36-2-228.
   Google Scholar
• Brahma U, Suresh A, Murthy S, Bhandari V, Sharma P. 2022. Antibiotic resistance and molecular profiling of the clinical isolates of Staphylococcus aureus causing bovine mastitis from India. Microorganisms. 10(4):833. doi:10.3390/microorganisms10040833.
   PubMed Web of Science ®Google Scholar
• Brandelli A, Ritter AC, Veras FF. 2017. Antimicrobial activities of metal nanoparticles. In Metal nanoparticles in pharma. Cham: Springer. p. 337–363. doi:10.1007/978–3–319–63790–7_15.
   Google Scholar
• Breijyeh Z, Jubeh B, Karaman R. 2020. Resistance of gram–negative bacteria to current antibacterial agents and approaches to resolve it. Molecules. 25(6):1340. doi:10.3390/molecules25061340.
   PubMed Web of Science ®Google Scholar
• Butnariu M, Quispe C, Herrera-Bravo J, Sharifi-Rad J, Singh L, Aborehab NM, Bouyahya A, Venditti A, Sen S, Acharya K, et al. 2022. The pharmacological activities of Crocus sativus L.: a review based on the mechanisms and therapeutic opportunities of its phytoconstituents. Oxid Med Cell Longev. 2022:8214821–8214829. Article ID 8214821. doi:10.1155/2022/8214821.
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect Dis. 5(11):685–694. doi:10.1016/S1473-3099(05)70267-X.
   PubMed Web of Science ®Google Scholar
• Carradori S, Chimenti P, Fazzari M, Granese A, Angiolella L. 2016. Antimicrobial activity, synergism and inhibition of germ tube formation by Crocus sativus–derived compounds against Candida spp. J Enzyme Inhib Med Chem. 31(sup2):189–193. doi:10.1080/14756366.2016.1180596.
   PubMed Web of Science ®Google Scholar
• CastañedaBarba S, Top EM, Stalder T. 2023. Plasmids, a molecular cornerstone of antimicrobial resistance in the One Health era. Nat Rev Microbiol. 22(1):18–32. doi:10.1038/s41579-023-00926-x.
   PubMed Web of Science ®Google Scholar
• Cattoir V. 2016. Streptococcus pyogenes Basic biology to clinical manifestations (Ferretti JJ, Stevens DL, Fischetti VA, editors). Oklahoma City: University of Oklahoma Health Sciences Center Library. p. 1–24
   Google Scholar
• Chavan R, Zope V, Chavan N, Patil K, Yeole R, Bhagwat S, Patel M. 2021. Assessment of the in vitro cytochrome P450 (CYP) inhibition potential of nafithromycin, a next generation lactone ketolide antibiotic. Xenobiotica. 51(3):251–261. doi:10.1080/00498254.2020.1839983.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. 2020. Selective organ targeting (SORT) nanoparticles for tissue–specific mRNA delivery and CRISPR–Cas gene editing. Nat Nanotechnol. 15(4):313–320. doi:10.1038/s41565–020–0669–6.
   PubMed Web of Science ®Google Scholar
• Chevalier J, Atifi S, Eyraud A, Mahamoud A, Barbe J, Pagès JM. 2001. New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. J Med Chem. 44(23):4023–4026. doi:10.1021/jm010911z.
   PubMed Web of Science ®Google Scholar
• Clinical Drug Experience Knowledgebase. 2023. Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects. https://www.cdek.liu.edu/trial/NCT04802863/
   Google Scholar
• ClinicalTrials 2023. A first in human study of the safety and tolerability of single and multiple doses of BWC0977 in healthy volunteers. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT05088421
   Google Scholar
• Cools P, Nemec A, Kämpfer P, et al. 2019. Acinetobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods. In: Manual of clinical microbiology. ASM Press. p. 829–857. doi:10.1128/9781555817381.ch44.
   Google Scholar
• CortezCordova J, Kumar A. 2011. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii. Int J Antimicrob Agents. 37(5):420–424. doi:10.1016/j.ijantimicag.2011.01.006.
   PubMed Web of Science ®Google Scholar
• Cristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E. 2023. An overview on Candida auris in healthcare settings. J Fungi (Basel). 9(9):913. doi:10.3390/jof9090913.
   PubMedGoogle Scholar
• da Silva RAG, Wong JJ, Antypas H, Choo PY, Goh K, Jolly S, Liang C, Tay Kwan Sing L, Veleba M, Hu G, et al. 2023. Mitoxantrone targets both host and bacteria to overcome vancomycin resistance in Enterococcus faecalis. Sci Adv. 9(8):eadd9280. doi:10.1126/sciadv.add9280.
   PubMed Web of Science ®Google Scholar
• Dai W, Zhang Y, Zhang J, Xue C, Yan J, Li X, Zheng X, Dong R, Bai J, Su Y, et al. 2021. Analysis of antibiotic–induced drug resistance of Salmonella enteritidis and its biofilm formation mechanism. Bioengineered. 12(2):10254–10263. doi:10.1080/21655979.2021.1988251.
   PubMed Web of Science ®Google Scholar
• Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, Blair JMA. 2023. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 21(5):280–295. doi:10.1038/s41579-022-00820-y.
   PubMed Web of Science ®Google Scholar
• David S, Reuter S, Harris SR, Glasner C, Feltwell T, Argimon S, Abudahab K, Goater R, Giani T, Errico G, et al. 2019. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol. 4(11):1919–1929. doi:10.1038/s41564-019-0492-8.
   PubMed Web of Science ®Google Scholar
• D’Cunha N, Moniruzzaman M, Haynes K, Malloci G, Cooper CJ, Margiotta E, Vargiu AV, Uddin MR, Leus IV, Cao F, et al. 2021. Mechanistic duality of bacterial efflux substrates and inhibitors: example of simple substituted cinnamoyl and naphthyl amides. ACS Infect Dis. 7(9):2650–2665. doi:10.1021/acsinfecdis.1c00100.
   PubMed Web of Science ®Google Scholar
• De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. 2020. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 33(3):10–128. doi:10.1128/cmr.00181-19.
   Web of Science ®Google Scholar
• De Sordi L, Khanna V, Debarbieux L. 2017. The gut microbiota facilitates drifts in the genetic diversity and infectivity of bacterial viruses. Cell Host Microbe. 22(6):801–808.e3. doi:10.1016/j.chom.2017.10.010.
   PubMed Web of Science ®Google Scholar
• Drawz SM, Bonomo RA. 2010. Three decades of β–lactamase inhibitors. Clin Microbiol Rev. 23(1):160–201. doi:10.1128/cmr.00037–09.
   PubMed Web of Science ®Google Scholar
• Durand GA, Raoult D, Dubourg G. 2019. Antibiotic discovery: history, methods and perspectives. Int J Antimicrob Agents. 53(4):371–382. doi:10.1016/j.ijantimicag.2018.11.010.
   PubMed Web of Science ®Google Scholar
• Eldholm V, Balloux F. 2016. Antimicrobial resistance in Mycobacterium tuberculosis: the odd one out. Trends Microbiol. 24(8):637–648. doi:10.1016/j.tim.2016.03.007.
   PubMed Web of Science ®Google Scholar
• Farhat N, Gupta D, Ali A, Kumar Y, Akhtar F, Kulanthaivel S, Mishra P, Khan F, Khan AU. 2022. Broad–spectrum inhibitors against class A, B, and C type β–lactamases to block the hydrolysis against antibiotics: kinetics and structural characterization. Microbiol Spectr. 10(5):e00450–22. doi:10.1128/spectrum.00450-22.
   PubMedGoogle Scholar
• Farhat N, Khan AU. 2020. Evolving trends of New Delhi Metallo–betalactamse (NDM) variants: a threat to antimicrobial resistance. Infect Genet Evol. 86:104588. doi:10.1016/j.meegid.2020.104588.
   PubMed Web of Science ®Google Scholar
• Farrag HA, Abdallah N, Shehata MMK, Awad EM. 2019. Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria. J Biomed Sci. 26(1):69. doi:10.1186/s12929–019–0561–6.
   PubMed Web of Science ®Google Scholar
• Fowler PD, Sharma S, Pant DK, Singh S, Wilkins MJ. 2021. Antimicrobial–resistant non–typhoidal Salmonella enterica prevalence among poultry farms and slaughterhouses in Chitwan, Nepal. Vet World. 14(2):437–445. doi:10.14202/vetworld.2021.437-445.
   PubMed Web of Science ®Google Scholar
• Gaiarsa S, Batisti Biffignandi G, Esposito EP, Castelli M, Jolley KA, Brisse S, Sassera D, Zarrilli R. 2019. Comparative analysis of the two Acinetobacter baumannii multilocus sequence typing (MLST) schemes. Front Microbiol. 10:930. doi:10.3389/fmicb.2019.00930.
   PubMed Web of Science ®Google Scholar
• Gill EE, Franco OL, Hancock RE. 2015. Antibiotic adjuvants: diverse strategies for controlling drug‐resistant pathogens. Chem Biol Drug Des. 85(1):56–78. doi:10.1111/cbdd.12478.
   PubMed Web of Science ®Google Scholar
• Gillespie EJ, Ho C-LC, Balaji K, Clemens DL, Deng G, Wang YE, Elsaesser HJ, Tamilselvam B, Gargi A, Dixon SD, et al. 2013. Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proc Natl Acad Sci U S A. 110(50):E4904–12. doi:10.1073/pnas.1302334110.
   PubMed Web of Science ®Google Scholar
• Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EW-C, Shu L, Yu J, Zhang R, et al. 2018. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 18(1):37–46. doi:10.1016/s1473-3099(17)30489-9.
   PubMed Web of Science ®Google Scholar
• Gundi VAKB, Dijkshoorn L, Burignat S, Raoult D, La Scola B. 2009. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology (Reading). 155(Pt 7):2333–2341. doi:10.1099/mic.0.026054-0.
   PubMedGoogle Scholar
• Hamidian M, Nigro SJ. 2019. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 5(10):e000306. doi:10.1099/mgen.0.000306.
   PubMed Web of Science ®Google Scholar
• Hsu J. 2020. How covid–19 is accelerating the threat of antimicrobial resistance. BMJ. 369:m1983. doi:10.1136/bmj.m1983.
   PubMedGoogle Scholar
• Huff WE, Huff GR, Rath NC, Balog JM, Donoghue AM. 2004. Therapeutic efficacy of bacteriophage and baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers. Poult Sci. 83(12):1944–1947. doi:10.1093/ps/83.12.1944.
   PubMed Web of Science ®Google Scholar
• Huynh B-T, Passet V, Rakotondrasoa A, Diallo T, Kerleguer A, Hennart M, Lauzanne AD, Herindrainy P, Seck A, Bercion R, et al. 2020. Klebsiella pneumoniae carriage in low-income countries: antimicrobial resistance, genomic diversity and risk factors. Gut Microbes. 11(5):1287–1299. doi:10.1080/19490976.2020.1748257.
   PubMed Web of Science ®Google Scholar
• Indian Council of Medical Research. 2022. Annual Report Antimicrobial Resistance Research and Surveillance Network. https://main.icmr.nic.in/sites/default/files/upload_documents/AMRSN_Annual_Report_2022.pdf
   Google Scholar
• Javaid N, Olwagen C, Nzenze S, Hawkins P, Gladstone R, McGee L, Breiman RF, Bentley SD, Madhi SA, Lo S, et al. 2022. Population genomics of pneumococcal carriage in South Africa following the introduction of the 13–valent pneumococcal conjugate vaccine (PCV13) immunization. Microb Genom. 8(6):000831. doi:10.1099/mgen.0.000831.
   Web of Science ®Google Scholar
• Jeannot K, Bolard A, Plésiat P. 2017. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 49(5):526–535. doi:10.1016/j.ijantimicag.2016.11.029.
   PubMed Web of Science ®Google Scholar
• Jolley KA, Bliss CM, Bennett JS, Bratcher HB, Brehony C, Colles FM, Wimalarathna H, Harrison OB, Sheppard SK, Cody AJ, et al. 2012. Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain. Microbiology. 158(4):1005–1015. doi:10.1099/mic.0.055459-0.
   PubMedGoogle Scholar
• Joya M, Aalemi AK, Baryali AT. 2022. Prevalence and antibiotic susceptibility of the common bacterial uropathogen among UTI patients in French Medical Institute for children. Infect Drug Resist. 15:4291–4297. doi:10.2147/IDR.S353818.
   Web of Science ®Google Scholar
• Karn RR, Acharya R, Rajbanshi AK, Singh SK, Thakur SK, Shah SK, Singh AK, Shah R, Upadhya Kafle S, Bhattachan M, et al. 2021. Antibiotic resistance in patients with chronic ear discharge awaiting surgery in Nepal. Public Health Action. 11(Suppl 1):1–5. doi:10.5588/pha.21.0029.
   Web of Science ®Google Scholar
• Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. 2018. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov. 17(1):35–56. doi:10.1038/nrd.2017.162.
   PubMed Web of Science ®Google Scholar
• Khalid S, Ahmad N, Ali SM, Khan AU. 2020. Outbreak of efficiently transferred carbapenem–resistant bla NDM–producing gram–negative bacilli isolated from neonatal intensive care unit of an Indian hospital. Microb Drug Resist. 26(3):284–289. doi:10.1089/mdr.2019.0092.
   Web of Science ®Google Scholar
• Khan, Asad U, Ali, Abid, Srivastava, Gaurava, Sharma, Ashok, Danishuddin,. 2017. Potential inhibitors designed against NDM–1 type metallo–β–lactamases: an attempt to enhance efficacies of antibiotics against multi–drug–resistant bacteria. Sci Rep 7(1):9207–. doi:10.1038/s41598–017–09588–1.
   PubMedGoogle Scholar
• Klobucar K, Côté J-P, French S, Borrillo L, Guo ABY, Serrano-Wu MH, Lee KK, Hubbard B, Johnson JW, Gaulin JL, et al. 2021. Chemical screen for vancomycin antagonism uncovers probes of the gram–negative outer membrane. ACS Chem Biol. 16(5):929–942. doi:10.1021/acschembio.1c00179.
   PubMed Web of Science ®Google Scholar
• Ko W-C, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, et al. 2002. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 8(2):160–166. doi:10.3201/eid0802.010025.
   PubMed Web of Science ®Google Scholar
• Komeda T, Shrestha S, Sherchan JB, Tohya M, Hishinuma T, Sherchand JB, Tada T, Kirikae T. 2022. Emergence of a highly colistin–resistant Aeromonas jandaei clinical isolate harbouring four genes encoding phosphoethanolamine transferases in Nepal. Int J Antimicrob Agents. 59(4):106544. doi:10.1016/j.ijantimicag.2022.106544.
   Web of Science ®Google Scholar
• Kortright KE, Chan BK, Koff JL, Turner PE. 2019. Phage therapy: a renewed approach to combat antibiotic–resistant bacteria. Cell Host Microbe. 25(2):219–232. doi:10.1016/j.chom.2019.01.014.
   PubMed Web of Science ®Google Scholar
• Kumar S, Mehrotra T, Talukdar D, Verma J, Chandra Karmakar B, Paul S, Chaudhuri S, Kumari Pragasam A, Bakshi S, Kumari S, et al. 2022. Region–specific genomic signatures of multidrug–resistant Helicobacter pylori isolated from East and South India. Gene. 847:146857. doi:10.1016/j.gene.2022.146857.
   Web of Science ®Google Scholar
• Kushwaha A, Pokharel K, Kadel AR. 2021. Antibiotic resistance to Escherichia coli among urine culture–positive patients in a tertiary care hospital in Nepal: a descriptive cross–sectional study. JNMA J Nepal Med Assoc. 59(233):39–41. doi:10.31729/jnma.5545.
   Web of Science ®Google Scholar
• Larsson DJ, Flach CF. 2022. Antibiotic resistance in the environment. Nat Rev Microbiol. 20(5):257–269. doi:10.1038/s41579–021–00649–x.
   PubMed Web of Science ®Google Scholar
• Laws M, Shaaban A, Rahman KM. 2019. Antibiotic resistance breakers: current approaches and future directions. FEMS Microbiol Rev. 43(5):490–516. doi:10.1093/femsre/fuz014.
   PubMed Web of Science ®Google Scholar
• Le Roux F, Blokesch M. 2018. Eco–evolutionary dynamics linked to horizontal gene transfer in Vibrios. Annu Rev Microbiol. 72(1):89–110. doi:10.1146/annurev–micro–090817–062148.
   Google Scholar
• Lenaerts A, Barry ICE, Dartois V. 2015. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol Rev. 264(1):288–307. doi:10.1111/imr.12252.
   PubMed Web of Science ®Google Scholar
• Leonard AFC, Zhang L, Balfour AJ, Garside R, Hawkey PM, Murray AK, Ukoumunne OC, Gaze WH. 2018. Exposure to and colonisation by antibiotic-resistant E. coli in UK coastal water users: environmental surveillance, exposure assessment, and epidemiological study (Beach Bum Survey). Environ. Int. 114:326–333. doi:10.1016/2016j.envint.2017.11.003.
   PubMed Web of Science ®Google Scholar
• Lepak AJ, Wang W, Andes DR. 2020. Pharmacodynamic evaluation of MRX-8, a novel polymyxin, in the neutropenic mouse thigh and lung infection models against Gram-negative pathogens. Antimicrob Agents Chemother. 64(11):10–128. doi:10.1128/aac.01517-20.
   Web of Science ®Google Scholar
• Lewis K, Ausubel FM. 2006. Prospects for plant–derived antibacterials. Nat Biotechnol. 24(12):1504–1507. doi:10.1038/nbt1206–1504.
   PubMed Web of Science ®Google Scholar
• Lewis K. 2013. Platforms for antibiotic discovery. Nat Rev Drug Discov. 12(5):371–387. doi:10.1038/nrd3975.
   PubMed Web of Science ®Google Scholar
• Liu B, Trout REL, Chu G-H, McGarry D, Jackson RW, Hamrick JC, Daigle DM, Cusick SM, Pozzi C, De Luca F, et al. 2020. Discovery of taniborbactam (VNRX-5133): a broad-spectrum serine-and metallo-β-lactamase inhibitor for carbapenem-resistant bacterial infections. J Med Chem. 63(6):2789–2801. doi:10.1021/acs.jmedchem.9b01518.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang L, Liu H, Cheng K. 2017. Delivery strategies of the CRISPR–Cas9 gene–editing system for therapeutic applications. J Control Release. 266:17–26. doi:10.1016/j.jconrel.2017.09.012.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tong Z, Shi J, Li R, Upton M, Wang Z. 2021. Drug repurposing for next–generation combination therapies against multidrug–resistant bacteria. Theranostics. 11(10):4910–4928. doi:10.7150/thno.56205.
   PubMed Web of Science ®Google Scholar
• Lomovskaya O, Tsivkovski R, Sun D, Reddy R, Totrov M, Hecker S, Griffith D, Loutit J, Dudley M. 2021. QPX7728, an ultra-broad-spectrum B-lactamase inhibitor for intravenous and oral therapy: overview of biochemical and microbiological characteristics. Front Microbiol. 12:697180. doi:10.3389/fmicb.2021.697180.
   Web of Science ®Google Scholar
• Lushniak BD. 2014. Antibiotic resistance: a public health crisis. Public Health Rep. 129(4):314–316. doi:10.1177/003335491412900402.
   PubMed Web of Science ®Google Scholar
• Mahlangu MP, Müller EE, Da Costa Dias B, Venter JME, Kularatne RS. 2022. Molecular characterization and detection of macrolide and fluoroquinolone resistance determinants in Mycoplasma genitalium in South Africa, 2015 to 2018. Sex Transm Dis. 49(7):511–516. doi:10.1097/OLQ.0000000000001631.
   Web of Science ®Google Scholar
• Mahmudul HM. 2021. Scenario of antibiotic resistance in developing countries. In: Antimicrobial resistance - A one health perspective. London, UK: IntechOpen. doi:10.5772/intechopen.94957.
   Google Scholar
• Mahto M, Chaudhary M, Shah A, Show KL, Moses FL, Stewart AG. 2021. High antibiotic resistance and mortality with Acinetobacter species in a tertiary hospital, Nepal. Public Health Action. 11(Suppl 1):13–17. doi:10.5588/pha.21.0036.
   Web of Science ®Google Scholar
• Malhotra-Kumar S, Xavier BB, Das AJ, Lammens C, Butaye P, Goossens H. 2016. Colistin resistance gene mcr–1 harboured on a multidrug resistant plasmid. Lancet Infect Dis. 16(3):283–284. doi:10.1016/s1473–3099(16)00012–8.
   PubMed Web of Science ®Google Scholar
• Malinga NZZ, Shobo CO, Molechan C, Amoako DG, Zishiri OT, Bester LA. 2022. Molecular surveillance and dissemination of Klebsiella pneumoniae on frequently encountered surfaces in South African Public Hospitals. Microb Drug Resist. 28(3):306–316. doi:10.1089/mdr.2020.0546.
   Web of Science ®Google Scholar
• Manzoor A, Ul-Haq I, Baig S, et al. 2016. Efficacy of locally isolated lactic acid bacteria against antibiotic–resistant uropathogens. Jundishapur J. Microbiol. 9(1):e18952. doi:10.5812/jjm.18952.
   PubMed Web of Science ®Google Scholar
• Martinez–Bond EA, Soriano BM, Williams AH. 2022. The mechanistic landscape of lytic transglycosylase as targets for antibacterial therapy. Curr Opin Struct Biol. 77:102480. doi:10.1016/j.sbi.2022.102480.
   Web of Science ®Google Scholar
• MarÝ-Almirall M, Cosgaya C, Higgins PG, et al. 2017. MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. áseifertii and A. ádijkshoorniae species. Clin. Microbiol. Infect. 23(3):210-e1. doi:10.1016/j.cmi.2016.11.020.
   Google Scholar
• Maryam L, Ali A, Khalid S, et al. 2020. A mechanistic approach to prove the efficacy of combination therapy against New Delhi metallo–β–lactamases producing bacterial strain: a molecular and biochemical approach. European J. Med. Res. 25:1–2. doi:10.1186/s40001–020–00418–1.
   Web of Science ®Google Scholar
• Maryam L, Khalid S, Ali A, Khan AU. 2019. Synergistic effect of doripenem in combination with cefoxitin and tetracycline in inhibiting NDM–1 producing bacteria. Future Microbiol. 14(8):671–689. doi:10.2217/fmb–2019–0032.
   PubMed Web of Science ®Google Scholar
• Maryam L, Khan AU. 2016. A mechanism of synergistic effect of streptomycin and cefotaxime on CTX–M–15 type β–lactamase producing strain of E. cloacae: a first report. Front Microbiol. 7:2007. doi:10.3389/fmicb.2016.02007.
   PubMed Web of Science ®Google Scholar
• Maryam L, Khan AU. 2017. Synergistic effect of doripenem and cefotaxime to inhibit CTX–M–15 type β–lactamases: biophysical and microbiological views. Front Pharmacol. 8:449. doi:10.3389/fphar.2017.00449.
   PubMed Web of Science ®Google Scholar
• Maryam L, Khan AU. 2018. Combination of aztreonam and cefotaxime against CTX–M–15 type β–lactamases: a mechanism based effective therapeutic approach. Int J Biol Macromol. 116:1186–1195. doi:10.1016/j.ijbiomac.2018.05.153.
   PubMed Web of Science ®Google Scholar
• Maryam L, Usmani SS, Raghava GP. 2021. Computational resources in the management of antibiotic resistance: speeding up drug discovery. Drug Discov Today. 26(9):2138–2151. doi:10.1016/j.drudis.2021.04.016.
   Web of Science ®Google Scholar
• Mathers AJ, Crook D, Vaughan A, Barry KE, Vegesana K, Stoesser N, Parikh HI, Sebra R, Kotay S, Walker AS, et al. 2019. Klebsiella quasipneumoniae provides a window into carbapenemase gene transfer, plasmid rearrangements, and patient interactions with the hospital environment. Antimicrob Agents Chemother. 63(6):10–128. doi:10.1128/aac.02513-18.
   Web of Science ®Google Scholar
• Matsumoto T, Mikamo H, Ohge H, Yanagihara K, Weerdenburg E, Go O, Spiessens B, van Geet G, van den Hoven T, Momose A, et al. 2022. Distribution of extraintestinal pathogenic Escherichia coli O–serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan. J Infect Chemother. 28(11):1445–1451. doi:10.1016/j.jiac.2022.07.001.
   Web of Science ®Google Scholar
• McLeod SM, Moussa SH, Hackel MA, Miller AA. 2020. In vitro activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex isolates collected globally in 2016 and 2017. Antimicrob Agents Chemother. 64(4):10–128. doi:10.1128/aac.02534-19.
   Web of Science ®Google Scholar
• Meatherall BL, Gregson D, Ross T, Pitout JDD, Laupland KB. 2009. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med. 122(9):866–873. doi:10.1016/j.amjmed.2009.03.034.
   PubMed Web of Science ®Google Scholar
• Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, Adhya S. 1996. Long–circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A. 93(8):3188–3192. doi:10.1073/pnas.93.8.3188.
   PubMed Web of Science ®Google Scholar
• Migliaccio A, Bray J, Intoccia M, Stabile M, Scala G, Jolley KA, Brisse S, Zarrilli R. 2023. Phylogenomics of Acinetobacter species and analysis of antimicrobial resistance genes. Front Microbiol. 14:1264030. doi:10.3389/fmicb.2023.1264030.
   PubMedGoogle Scholar
• Miura M, Shigemura K, Osawa K, et al. 2022. Genetic characteristics of azithromycin–resistant Neisseria gonorrhoeae collected in Hyogo, Japan during 2015–2019. J Med Microbiol. 71(6):001533. doi:10.1099/jmm.0.001533.
   Web of Science ®Google Scholar
• Mobasseri G, Thong KL, Teh CS. 2021. Genomic analysis revealing the resistance mechanisms of extended–spectrum β–lactamase–producing Klebsiella pneumoniae isolated from pig and humans in Malaysia. Int Microbiol. 24(2):243–250. doi:10.1007/s10123–021–00161–5.
   Web of Science ®Google Scholar
• More N, Kharat K, Kharat A. 2017. Berberine from Argemone mexicana L exhibits a broadspectrum antibacterial activity. Acta Biochim Pol. 64(4):653–660. doi:10.18388/abp.2017_1621.
   Web of Science ®Google Scholar
• Moreno-Gamez S, Hill AL, Rosenbloom DIS, Petrov DA, Nowak MA, Pennings PS. 2015. Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance. Proc Natl Acad Sci U S A. 112(22):E2874–83. doi:10.1073/pnas.1424184112.
   Web of Science ®Google Scholar
• Munguia J, Nizet V. 2017. Pharmacological targeting of the host–pathogen interaction: alternatives to classical antibiotics to combat drug-resistant superbugs. Trends Pharmacol Sci. 38(5):473–488. doi:10.1016/j.tips.2017.02.003.
   PubMed Web of Science ®Google Scholar
• Munita JM, Arias CA. 2016. Mechanisms of antibiotic resistance. Microbiol Spectr. 4(2): doi:10.1128/microbiolspec.vmbf–0016–2015.
   Web of Science ®Google Scholar
• Naeemmudeen NM, Mohd Ghazali NAN, Bahari H, Ibrahim R, Samsudin AD, Jasni AS. 2021. Trends in antimicrobial resistance in Malaysia. Med J Malaysia. 76(5):698–705.
   Google Scholar
• Naimi HM, André C, Bes M, Tristan A, Gustave C-A, Vandenesch F, Nazari QA, Laurent F, Dupieux C. 2021. Antibiotic resistance profile and molecular characterization of Staphylococcus aureus strains isolated in hospitals in Kabul, Afghanistan. Eur J Clin Microbiol Infect Dis. 40(5):1029–1038. doi:10.1007/s10096–020–04130–0.
   Web of Science ®Google Scholar
• Nakamura-Silva R, Cerdeira L, Oliveira-Silva M, da Costa KRC, Sano E, Fuga B, Moura Q, Esposito F, Lincopan N, Wyres K, et al. 2022. Multidrug–resistant Klebsiella pneumoniae: a retrospective study in Manaus, Brazil. Arch Microbiol. 204(4):202. doi:10.1007/s00203–022–02813–0.
   Web of Science ®Google Scholar
• National Center for Biotechnology Information. 2022a. PubChem compound summary for CID 9835049, Avibactam. https://pubchem.ncbi.nlm.nih.gov/compound/Avibactam
   Google Scholar
• National Center for Biotechnology Information. 2022b. PubChem compound summary for CID 123630, Tazobactam. https://pubchem.ncbi.nlm.nih.gov/compound/Tazobactam
   Google Scholar
• National Center for Biotechnology Information. 2022c. PubChem compound summary for CID 44129647, Relebactam. https://pubchem.ncbi.nlm.nih.gov/compound/Relebactam
   Google Scholar
• National Center for Biotechnology Information. 2022d. PubChem compound summary for CID 130313, Sulbactam. https://pubchem.ncbi.nlm.nih.gov/compound/Sulbactam
   Google Scholar
• National Center for Biotechnology Information. 2022e. PubChem compound summary for CID 5280980, Clavulanic acid. https://pubchem.ncbi.nlm.nih.gov/compound/Clavulanic–acid
   Google Scholar
• NBC news 2023. At least 2 cases of drug-resistant ringworm infections found in the U.S., CDC says. https://www.nbcnews.com/health/health-news/least-two-cases-drug-resistant-ringworm-infections-found-us-cdc-says-rcna83918
   Google Scholar
• Nguyen S, Baker K, Padman BS, Patwa R, Dunstan RA, Weston TA, Schlosser K, Bailey B, Lithgow T, Lazarou M, et al. 2017. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. MBio. 8(6):10–128. doi:10.1128/mbio.01874-17.
   Web of Science ®Google Scholar
• Nguyen THT, Nguyen HD, Le MH, Nguyen TTH, Nguyen TD, Nguyen DL, Nguyen QH, Nguyen TKO, Michalet S, Dijoux-Franca M-G, et al. 2023. Efflux pump inhibitors in controlling antibiotic resistance: outlook under a heavy metal contamination context. Molecules. 28(7):2912. doi:10.3390/molecules28072912.
   Web of Science ®Google Scholar
• Nieth A, Verseux C, Römer W. 2015. A question of attire: dressing up bacteriophage therapy for the battle against antibiotic-resistant intracellular bacteria. Springer Sc. Rev. 3(1):1–11. doi:10.1007/s40362-014-0027-x.
   Google Scholar
• Nikaido H. 2009. Multidrug resistance in bacteria. Annu Rev Biochem. 78(1):119–146. doi:10.1146/annurev.biochem.78.082907.145923.
   PubMedGoogle Scholar
• Nikolich MP, Filippov AA. 2020. Bacteriophage therapy: developments and directions. Antibiotics (Basel). 9(3):135. doi:10.3390/antibiotics9030135.
   PubMed Web of Science ®Google Scholar
• Oechslin F, Piccardi P, Mancini S, Gabard J, Moreillon P, Entenza JM, Resch G, Que Y-A. 2017. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J Infect Dis. 215(5):703–712. doi:10.1093/infdis/jiw632.
   PubMed Web of Science ®Google Scholar
• Ogawara H. 2019. Comparison of antibiotic resistance mechanisms in antibiotic–producing and pathogenic bacteria. Molecules. 24(19):3430. doi:10.3390/molecules24193430.
   Web of Science ®Google Scholar
• Otto RG, van Gorp E, Kloezen W, Meletiadis J, van den Berg S, Mouton JW. 2019. An alternative strategy for combination therapy: interactions between polymyxin B and non-antibiotics. Int J Antimicrob Agents. 53(1):34–39. doi:10.1016/j.ijantimicag.2018.09.003.
   PubMed Web of Science ®Google Scholar
• Paintsil EK, Ofori LA, Adobea S, Akenten CW, Phillips RO, Maiga-Ascofare O, Lamshöft M, May J, Obiri Danso K, Krumkamp R, et al. 2022. Prevalence and antibiotic resistance in Campylobacter spp. isolated from humans and food–producing animals in West Africa: a systematic review and meta–analysis. Pathogens. 11(2):140. doi:10.3390/pathogens11020140.
   Web of Science ®Google Scholar
• Pal C, Bengtsson-Palme J, Kristiansson E, Larsson DGJ. 2016. The structure and diversity of human, animal and environmental resistomes. Microbiome. 4(1):54. doi:10.1186/s40168-016-0199-5.
   PubMedGoogle Scholar
• Palwe S, Bakthavatchalam YD, Khobragadea K, Kharat AS, Walia K, Veeraraghavan B. 2021. In-vitro selection of ceftazidime/avibactam resistance in OXA-48-like-expressing Klebsiella pneumoniae: in-vitro and in-vivo fitness, genetic basis and activities of β-lactam plus novel β-lactamase inhibitor or β-lactam enhancer combinations. Antibiotics (Basel). 10(11):1318. doi:10.3390/antibiotics10111318.
   Web of Science ®Google Scholar
• Park JY, Moon BY, Park JW, Thornton JA, Park YH, Seo KS. 2017. Genetic engineering of a temperate phage–based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus. Sci Rep. 7(1):44929. doi:10.1038/srep44929.
   PubMedGoogle Scholar
• Pelgrift RY, Friedman AJ. 2013. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 65(13-14):1803–1815. doi:10.1016/j.addr.2013.07.011.
   PubMed Web of Science ®Google Scholar
• Pendleton JN, Gorman SP, Gilmore BF. 2013. Clinical relevance of the ESKAPE pathogens. Expert Rev anti Infect Ther. 11(3):297–308. doi:10.1586/eri.13.12.
   PubMed Web of Science ®Google Scholar
• Penn-Nicholson A, Georghiou SB, Ciobanu N, Kazi M, Bhalla M, David A, Conradie F, Ruhwald M, Crudu V, Rodrigues C, et al. 2022. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross–sectional multicentre diagnostic accuracy study. Lancet Infect Dis. 22(2):242–249. doi:10.1016/S1473–3099(21)00452–7.
   Web of Science ®Google Scholar
• Perovic O, Duse A, Chibabhai V, Black M, Said M, Prentice E, Wadula J, Mahabeer Y, Han KSS, Mogokotleng R, et al. 2022. Acinetobacter baumannii complex, national laboratory–based surveillance in South Africa, 2017 to 2019. PLoS One. 17(8):e0271355. doi:10.1371/journal.pone.0271355.
   Web of Science ®Google Scholar
• Pi H, Nguyen HT, Venter H, Boileau AR, Woolford L, Garg S, Page SW, Russell CC, Baker JR, McCluskey A, et al. 2020. In vitro activity of robenidine analog NCL195 in combination with outer membrane permeabilizers against gram–negative bacterial pathogens and impact on systemic gram–positive bacterial infection in mice. Front Microbiol. 11:1556. doi:10.3389/fmicb.2020.01556.
   Web of Science ®Google Scholar
• Podschun R, Ullmann U. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 11(4):589–603. doi:10.1128/cmr.11.4.589.
   PubMed Web of Science ®Google Scholar
• PubChem. 2004a. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information. PubChem compound summary for CID 2603, (3-Chlorophenyl) hydrazonomalononitrile. https://pubchem.ncbi.nlm.nih.gov/compound/3-Chlorophenyl_hydrazonomalononitrile
   Google Scholar
• PubChem. 2004b. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information. PubChem compound summary for CID 40492789. https://pubchem.ncbi.nlm.nih.gov/compound/40492789
   Google Scholar
• Ramirez DM, Ramirez D, Arthur G, et al. 2022. Guanidinylated polymyxins as outer membrane permeabilizers capable of potentiating rifampicin, erythromycin, ceftazidime and aztreonam against gram–negative bacteria. Antibiotics. 11(10):1277. doi:10.3390/antibiotics11101277.
   Google Scholar
• Rather MA, Gupta K, Mandal M. 2021. Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. Braz J Microbiol. 52(4):1701–1718. doi:10.1007/s42770–021–00624–x.
   Web of Science ®Google Scholar
• Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. 2020. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID–19 antimicrobial prescribing. Clin Infect Dis. 71(9):2459–2468. doi:10.1093/cid/ciaa530.
   PubMed Web of Science ®Google Scholar
• Roberts T, Dahal P, Shrestha P, Schilling W, Shrestha R, Ngu R, Huong VTL, van Doorn HR, Phimolsarnnousith V, Miliya T, et al. 2022. Antimicrobial resistance patterns in bacteria causing febrile illness in Africa, South Asia and Southeast Asia: a systematic review of published aetiological studies from 1980–2015. Int J Infect Dis. 122:612–621. doi:10.1016/j.ijid.2022.07.018.
   Web of Science ®Google Scholar
• Rodrigues M, McBride SW, Hullahalli K, Palmer KL, Duerkop BA. 2019. Conjugative delivery of CRISPR–Cas9 for the selective depletion of antibiotic–resistant enterococci. Antimicrob Agents Chemother. 63(11):e01454–19. doi:10.1128/aac.01454–19.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Medina N, Barrios-Camacho H, Duran-Bedolla J, Garza-Ramos U. 2019. Klebsiella variicola: an emerging pathogen in humans. Emerg Microbes Infect. 8(1):973–988. doi:10.1080/22221751.2019.1634981.
   PubMed Web of Science ®Google Scholar
• Saito R, Nakajima J, Prah I, et al. 2022. Penicillin–and ciprofloxacin–resistant invasive Neisseria meningitidis isolates from. Japan. Microbiol. Spectr. 10(3):e00627. 22. doi:10.1128/spectrum.00627–22.
   Web of Science ®Google Scholar
• Sánchez-Busó L, Yeats CA, Taylor B, Goater RJ, Underwood A, Abudahab K, Argimón S, Ma KC, Mortimer TD, Golparian D, et al. 2021. A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch. Genome Med. 13(1):61. doi:10.1186/s13073-021-00858-2.
   PubMed Web of Science ®Google Scholar
• Sanchez-Carbonel A, Mondragón B, López-Chegne N, Peña-Tuesta I, Huayan-Dávila G, Blitchtein D, Carrillo-Ng H, Silva-Caso W, Aguilar-Luis MA, Del Valle-Mendoza J, et al. 2021. The effect of the efflux pump inhibitor Carbonyl Cyanide m–Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii. PLoS One. 16(12):e0259915. doi:10.1371/journal.pone.0259915.
   Web of Science ®Google Scholar
• Sanduja P, Gupta M, Somani VK, Yadav V, Dua M, Hanski E, Sharma A, Bhatnagar R, Johri AK. 2020. Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191. Nat Commun. 11(1):3545. doi:10.1038/s41467-020-17299.
   Web of Science ®Google Scholar
• Sasaki Y, Yonemitsu K, Uema M, Asakura H, Asai T. 2022. Prevalence and antimicrobial resistance of Campylobacter and Salmonella in layer flocks in Honshu, Japan. J. J Vet Med Sci. 84(11):1502–1507. doi:10.1292/jvms.22–0257.
   Web of Science ®Google Scholar
• Sawatzky P, Demczuk W, Lefebvre B, et al. 2015. Increasing azithromycin resistance in Neisseria gonorrhoeae due to NG–MAST 12302 clonal spread in Canada. to. Antimicrob. 66(3):2022–2018. e01688–21. doi:10.1128/AAC.01688–21.
   Google Scholar
• Šedo O, Radolfová-Křížová L, Nemec A, Zdráhal Z. 2018. Limitations of routine MALDI-TOF mass spectrometric identification of Acinetobacter species and remedial actions. J Microbiol Methods. 154:79–85. doi:10.1016/j.mimet.2018.10.009.
   PubMed Web of Science ®Google Scholar
• Selden R, Lee S, Wang WL, Bennett JV, Eickhoff TC. 1971. Nosocomial Klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med. 74(5):657–664. doi:10.7326/0003-4819-74-5-657.
   PubMed Web of Science ®Google Scholar
• Sen K, Berglund T, Patel N, Chhabra N, Ricci DM, Dutta S, Mukhopadhyay AK. 2022. Genotypic analyses and antimicrobial resistance profiles of Campylobacter jejuni from crows (Corvidae) of United States and India reflect their respective local antibiotic burdens. J Appl Microbiol. 132(1):696–706. doi:10.1111/jam.15220.
   Web of Science ®Google Scholar
• Sharma A, Gupta VK, Pathania R. 2019. Efflux pump inhibitors for bacterial pathogens: from bench to bedside. Indian J Med Res. 149(2):129–145. doi:10.4103/ijmr.IJMR_2079_17.
   PubMed Web of Science ®Google Scholar
• Sharma A, Kumar Arya D, Dua M, Chhatwal GS, Johri AK. 2012. Nano–technology for targeted drug delivery to combat antibiotic resistance. Expert Opin Drug Deliv. 9(11):1325–1332. doi:10.1517/17425247.2012.717927.
   PubMed Web of Science ®Google Scholar
• Sharma G, Dang S, K A, Kalia M, Gabrani R. 2020. Synergistic antibacterial and anti-biofilm activity of nisin like bacteriocin with curcumin and cinnamaldehyde against ESBL and MBL producing clinical strains. Biofouling. 36(6):710–724. doi:10.1080/08927014.2020.1804553.
   PubMed Web of Science ®Google Scholar
• Shaw S, Samanta P, Chowdhury G, Ghosh D, Dey TK, Deb AK, Ramamurthy T, Miyoshi S-I, Ghosh A, Dutta S, et al. 2022. Altered molecular attributes and antimicrobial resistance patterns of Vibrio cholerae O1 El Tor strains isolated from the cholera endemic regions of India. J Appl Microbiol. 133(6):3605–3616. doi:10.1111/jam.15794.
   Web of Science ®Google Scholar
• Shen D, Ma G, Li C, Jia X, Qin C, Yang T, Wang L, Jiang X, Ding N, Zhang X, et al. 2019. Emergence of a multidrug-resistant hypervirulent Klebsiella pneumoniae sequence type 23 strain with a rare bla CTX-M-24-harboring virulence plasmid. Antimicrob Agents Chemother. 63(3):10–128. doi:10.1128/aac.02273-18.
   Web of Science ®Google Scholar
• Shon AS, Bajwa RP, Russo TA. 2013. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 4(2):107–118. doi:10.4161/viru.22718.
   PubMed Web of Science ®Google Scholar
• Shrestha LB, Syangtan G, Basnet A, Acharya KP, Chand AB, Pokhrel K. 2021. Methicillin–resistant Staphylococcus aureus in Nepal. JNMA J Nepal Med Assoc. 59(237):518–522. doi:10.31729/jnma.6251.
   Web of Science ®Google Scholar
• Singh L, Cariappa MP, Kaur M. 2016. Klebsiella oxytoca: an emerging pathogen? Med J Armed Forces India. 72(Suppl 1):S59–S61. doi:10.1016/j.mjafi.2016.05.002.
   Google Scholar
• Sousa EO, Carneiro RTO, Montes FCOF, et al. 2022. Laboratory–based study of drug resistance and genotypic profile of multidrug–resistant tuberculosis isolates in Salvador, Bahia. Brazil Rev Soc Bras Med Trop. 55:e00132022. doi:10.1590/0037–8682–0013–2022.
   Web of Science ®Google Scholar
• Sundaresan AK, Vincent K, Mohan GBM, Ramakrishnan J. 2022. Association of sequence types, antimicrobial resistance and virulence genes in Indian isolates of Klebsiella pneumoniae: a comparative genomics study. J Glob Antimicrob Resist. 30:431–441. doi:10.1016/j.jgar.2022.05.006.
   Web of Science ®Google Scholar
• Tiwari M, Kumar P, Tejavath KK, Tiwari V. 2020. Assessment of molecular mechanism of gallate-polyvinylpyrrolidone-capped hybrid silver nanoparticles against carbapenem-resistant Acinetobacter baumannii. ACS Omega. 5(2):1206–1213. doi:10.1021/acsomega.9b03644.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Kapil A, Moganty RR. 2012. Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. Microb Pathog. 53(2):81–86. doi:10.1016/j.micpath.2012.05.004.
   Web of Science ®Google Scholar
• Tiwari V, Mishra N, Gadani K, Solanki PS, Shah NA, Tiwari M. 2018. Mechanism of anti-bacterial activity of zinc oxide nanoparticle against carbapenem-resistant Acinetobacter baumannii. Front Microbiol. 9:1218. doi:10.3389/fmicb.2018.01218.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Tiwari M, Solanki V. 2017. Polyvinylpyrrolidone-capped silver nanoparticle inhibits infection of carbapenem-resistant strain of Acinetobacter baumannii in the human pulmonary epithelial cell. Front Immunol. 8:973. doi:10.3389/fimmu.2017.00973.
   Web of Science ®Google Scholar
• Tropical Medicine. 2023. Global Research on AntiMicrobial resistance (GRAM) project. https://www.tropicalmedicine.ox.ac.uk/news/global-burden-of-bacterial-antimicrobial-resistance
   Google Scholar
• Tuon FF, Rocha JL, Formigoni–Pinto MR. 2018. Pharmacological aspects and spectrum of action of ceftazidime–avibactam: a systematic review. Infection. 46(2):165–181. doi:10.1007/s15010–017–1096–y.
   PubMed Web of Science ®Google Scholar
• Ugwuanyi FC, Ajayi A, Ojo DA, Adeleye AI, Smith SI. 2021. Evaluation of efflux pump activity and biofilm formation in multidrug resistant clinical isolates of Pseudomonas aeruginosa isolated from a Federal Medical Center in Nigeria. Ann Clin Microbiol Antimicrob. 20(1):11. doi:10.1186/s12941–021–00417–y.
   Web of Science ®Google Scholar
• Ventola CL. 2015. The antibiotic resistance crisis: part 1: causes and threats. P T. 40(4):277–283.
   PubMedGoogle Scholar
• Verma S, Kumari M, Pathak A, Yadav V, Johri AK, Yadav P. 2023. Antibiotic resistance, biofilm formation, and virulence genes of Streptococcus agalactiae serotypes of Indian origin. BMC Microbiol. 23(1):176. doi:10.1186/s12866-023-02877-y.
   Web of Science ®Google Scholar
• Vrancianu CO, Gheorghe I, Dobre E-G, Barbu IC, Cristian RE, Popa M, Lee SH, Limban C, Vlad IM, Chifiriuc MC, et al. 2020. Emerging strategies to combat β–lactamase producing ESKAPE pathogens. Int J Mol Sci. 21(22):8527. doi:10.3390/ijms21228527.
   Web of Science ®Google Scholar
• Walesch S, Birkelbach J, Jézéquel G, Haeckl FPJ, Hegemann JD, Hesterkamp T, Hirsch AKH, Hammann P, Müller R. 2023. Fighting antibiotic resistance—strategies and (pre) clinical developments to find new antibacterials. EMBO Reports. 24(1):e56033. doi:10.15252/embr.202256033.
   Web of Science ®Google Scholar
• Wan F, Draz MS, Gu M, Yu W, Ruan Z, Luo Q. 2021. Novel strategy to combat antibiotic resistance: a sight into the combination of CRISPR/Cas9 and nanoparticles. Pharmaceutics. 13(3):352. doi:10.3390/pharmaceutics13030352.
   PubMed Web of Science ®Google Scholar
• Wang J, Chu L, Wojnárovits L, Takács E. 2020. Occurrence and fate of antibiotics, antibiotic resistant genes (ARGs) and antibiotic resistant bacteria (ARB) in municipal wastewater treatment plant: an overview. Sci Total Environ. 744:140997. doi:10.1016/j.scitotenv.2020.140997.
   PubMed Web of Science ®Google Scholar
• White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B. 2004. Augmentin®(amoxicillin/clavulanate) in the treatment of community–acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J Antimicrob Chemother. 5(suppl_1):i3–20. doi:10.1093/jac/dkh050.
   Google Scholar
• WHO. 2022. 2021 Antibacterial agents in clinical and preclinical development: an overview and analysis. https://www.who.int/publications/i/item/9789240047655
   Google Scholar
• WHO. 2023a. Antimicrobial Resistance: briefing to WHO mem­ber states. https://apps.who.int/gb/MSPI/pdf_files/2023/03/Item1_22-03.pdf
   Google Scholar
• WHO. 2023b. Global Tuberculosis Report 2016. World Health Organization http://www.who.int/tb/publications/global_report/en/2016
   Google Scholar
• Williams A, Wheeler R, Thiriau C, Haouz A, Taha M, Boneca I. 2017. Bulgecin A: the key to a broad–spectrum inhibitor that targets lytic transglycosylases. Antibiotics. 6(1):8. doi:10.3390/antibiotics6010008.
   Google Scholar
• Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. 2017. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 30(1):409–447. doi:10.1128/cmr.00058-16.
   PubMed Web of Science ®Google Scholar
• World Bank 2023. Antimicrobial Resistance (AMR). https://www.worldbank.org/en/topic/health/brief/antimicrobial–resistance
   Google Scholar
• World Health Organization. 2019a. New report calls for ur­gent action to avert antimicrobial resistance crisis. https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis
   Google Scholar
• World Health Organization. 2019b. Antibacterial agents in clinical development: an analysis of the antibacterial clini­cal development pipeline. https://www.who.int/publications/i/item/9789240000193
   Google Scholar
• Wozniak TM, Dyda A, Merlo G, Hall L. 2022. Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia. Lancet Reg Health West Pac. 27:100521. doi:10.1016/j.lanwpc.2022.100521.
   Google Scholar
• Yadav JP, Kaur S, Dhaka P, Vijay D, Bedi JS. 2022. Prevalence, molecular characterization, and antimicrobial resistance profile of Clostridium perfringens from India: a scoping review. Anaerobe. 77:102639. doi:10.1016/j.anaerobe.2022.102639.
   PubMed Web of Science ®Google Scholar
• Zechini B, Versace I. 2009. Inhibitors of multidrug ­resistant efflux systems in bacteria. Recent Pat Antiinfect Drug Discov. 4(1):37–50. doi:10.2174/157489109787236256.
   PubMedGoogle Scholar
• Zhanel GG, Pozdirca M, Golden AR, Lawrence CK, Zelenitsky S, Berry L, Schweizer F, Bay D, Adam H, Zhanel MA, et al. 2022. Sulopenem: an intravenous and oral penem for the treatment of urinary tract infections due to multidrug-resistant bacteria. Drugs. 82(5):533–557. doi:10.1007/s40265-022-01688-1.
   Web of Science ®Google Scholar
• Zhen X, Lundborg CS, Sun X, Hu X, Dong H. 2019. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 8(1):137. doi:10.1186/s13756–019–0590–7.
   PubMed Web of Science ®Google Scholar
• Zhu Y-G, Zhao Y, Zhu D, Gillings M, Penuelas J, Ok YS, Capon A, Banwart S. 2019. Soil biota, antimicrobial resistance and planetary health. Environ Int. 131:105059. doi:10.1016/j.envint.2019.105059.
   PubMed Web of Science ®Google Scholar